🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT07839338
Starting soon Phase 3

A Study Comparing Oral Ketamine With Oral Midazolam for the Treatment of Major Depressive Episodes

NCT07839338 · tracked via the Priya Life Science India tracker
Sponsor
Jawaharlal Institute of Postgraduate Medical Education & Research
Phase
Phase 3
Started
2026-10
Last updated
2026-09-24

Condition(s) studied

Major Depressive Episode

Investigational drug(s) / intervention(s)

Oral ketamine →Oral midazolam →

Oral ketamine: Nine sessions of oral ketamine

Oral midazolam: Nine sessions of oral midazolam

Study summary

Patients with depression are acutely distressed, often suicidal, and unable to meet the demands of everyday life. If proven effective in a rigorously conducted multicenter randomized controlled trial (RCT), oral ketamine would provide an affordable and scalable, intervention suitable for integration into routine psychiatric services.This study will establish an indigenous, cost-effective therapeutic strategy that could improve accessibility, hasten therapeutic response, and inform treatment guidelines, if found to be safe and effective.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Consenting adult outpatients or inpatients with at least moderately severe major depressive episode (MDE), denoted by HAM- D more than or equal to 20, associated with major depressive disorder or bipolar disorder, with diagnosis confirmed using a structured diagnostic interview. Exclusion Criteria: * Patients with co-morbid obsessive-compulsive disorder or intellectual disability disorder or co-morbid substance dependence other than nicotine or patients concurrently receiving neuromodulation treatments or those with psychotic symptoms. Patients with current or ongoing suicide risk, such as active suicidal ideation with a specific plan or some intent in the last 3 days, will be excluded if they are treated as outpatients. Patients in whom, in the subjective opinion of the PI, the MDE symptoms appear to be significantly driven by acute life events or circumstances. Patients with abnormalities of concern detected in the electrocardiogram, or with uncontrolled hypertension or those with ongoing pregnancy or lactation

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
NIMHANS Bangalore Karnataka
Kasturba Medical College Udupi Karnataka
MGM Medical College, Mumbai Mumbai Maharashtra
AIIMS, Bhubaneswar Bhubaneswar Odisha
Jawaharlal Institute of Postgraduate Medical Education and Research Puducherry Puducherry
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07839338 on ClinicalTrials.gov ↗ ← All trials in India